Akero Therapeutics, Inc.
Industry: Life Sciences ・ $AKRO on Nasdaq
Insider Sale
+$386,684
-15.62%
Shares
Shares Volume: 14,051 Shares
Average Share Price: $27.52
INSIDER
Yale Catriona
Chief Development Officer (Officer)
reported on Aug 28 2024
traded on Aug 23 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 75,931 |
| PURCHASES/SALES 1Y | 0 / 7 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $254,229.76 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 1 |
| PURCHASES/SALES 1Y | 2 / 38 |
| P/S VALUE RATIO | 0.252 |
| AVERAGE SALE VALUE | $384,482.58 |
| COMPANY PREVIOUS TRADES |